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Abstract
Generative models of neuroimaging and electrophysiological data present new opportunities for accessing hidden or latent
brain states. Dynamic causal modeling (DCM) uses Bayesian model inversion and selection to infer the synaptic mechanisms
underlying empirically observed brain responses. DCM for electrophysiological data, in particular, aims to estimate the
relative strength of synaptic transmission at different cell types and via specific neurotransmitters. Here, we report a DCM
validation study concerning inference on excitatory and inhibitory synaptic transmission, using different doses of a volatile
anaesthetic agent (isoflurane) to parametrically modify excitatory and inhibitory synaptic processing while recording local
field potentials (LFPs) from primary auditory cortex (A1) and the posterior auditory field (PAF) in the auditory belt region in
rodents. We test whether DCM can infer, from the LFP measurements, the expected drug-induced changes in synaptic
transmission mediated via fast ionotropic receptors; i.e., excitatory (glutamatergic) AMPA and inhibitory GABAA receptors.
Cross- and auto-spectra from the two regions were used to optimise three DCMs based on biologically plausible neural
mass models and specific network architectures. Consistent with known extrinsic connectivity patterns in sensory
hierarchies, we found that a model comprising forward connections from A1 to PAF and backward connections from PAF to
A1 outperformed a model with forward connections from PAF to A1 and backward connections from A1 to PAF and a
model with reciprocal lateral connections. The parameter estimates from the most plausible model indicated that the
amplitude of fast glutamatergic excitatory postsynaptic potentials (EPSPs) and inhibitory postsynaptic potentials (IPSPs)
behaved as predicted by previous neurophysiological studies. Specifically, with increasing levels of anaesthesia,
glutamatergic EPSPs decreased linearly, whereas fast GABAergic IPSPs displayed a nonlinear (saturating) increase. The
consistency of our model-based in vivo results with experimental in vitro results lends further validity to the capacity of DCM
to infer on synaptic processes using macroscopic neurophysiological data.
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Introduction
Neural mass models have been used to simulate the electro-
physiological response of cortical regions and have recently served
as generative models for empirical M/EEG and LFP data
[1,2,3,4,5,6,7,8,9]. These models furnish mathematical descrip-
tions of detailed physiological processes including thalamic burst
firing [1], spike frequency adaptation [10], neuronal noise [11],
nonlinear channel conductances [12] and neuromodulation [13].
Of particular interest to empirical neuroscience is the inversion or
fitting of these generative models to real experimental data, where
mechanistic hypotheses regarding the genesis of data features can
be tested. Dynamic causal modelling (DCM) provides a general
framework in which neuronal ensemble models are inverted or
‘fitted’ to data. A particular ensemble model, known as an alpha-
kernel model [14] is often used within DCMs of M/EEG and LFP
data. The form of the dynamics is constrained by parameters that
encode the strength of transmission at different types of synapses.
Clearly, it is important to provide construct validity for these
model parameters and ensure that they have a physiological
interpretability. In this paper, we address this issue using LFP
signals, acquired by invasive recordings in rat auditory cortex,
under different levels of anaesthesia. This work is one from a series
of ongoing validation studies of the models employed in DCM for
electrophysiological data [15] using invasive recordings. Here, we
focus on the ability of DCM to infer on specific aspects of synaptic
transmission, i.e., whether it obtains plausible estimates of
experimentally induced changes in transmission at excitatory
glutamatergic synapses vs. inhibitory GABAergic synapses.
Pharmacological interventions can manipulate aspects of
synaptic processing and can thus be used to validate model
predictions: Here, we use isoflurane, a volatile anaesthetic agent
that is used commonly in animal laboratory studies [16]. While,
compared to other pharmacological agents, it induces a diverse
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signalling both pre- and postsynaptically, the resulting net effect at
the neuronal circuit level is a decrease in excitation and an
increase in inhibition [17]. Studies of specific presynaptic and
postsynaptic effects of volatile anaesthetics have demonstrated
actions on both the release of neurotransmitters and the function
of neurotransmitter receptors [18]. Particular attention has been
on inhibitory neurotransmission, where increased inhibition in the
presence of isoflurane has been attributed to a sensitisation of
GABAA receptors [18], but also to increased synaptic release of
GABA [19]. Glutamatergic neurotransmission has also been
reported to be directly affected by isoflurane. Isoflurane reduces
the strength of synaptic signalling following activation of both non-
NMDA [20,21] and in some cases to a greater [22] or equal [23]
degree of NMDA receptors, as well as leading to its diminished
release [21,24]. Sophisticated biophysical models of anaesthesia
have been developed to explain the theoretical properties they
induce, such as phase transitions and hysteresis at transitions of
consciousness [25,26] and to examine observed side effects such as
epilepsy [27,28]. In this study, we use a coarser neural mass model
[29] that embodies a lumped representation of biophysical
processes underlying synaptic functions. In other words, processes
such as presynaptic release and reuptake of transmitters or binding
of transmitters to postsynaptic receptors are not modelled
explicitly. Instead, the model absorbs these detailed processes into
a slightly more abstract representation, modelling postsynaptic
effects as the convolution of presynaptic inputs with postsynaptic
kernels [4]. The magnitude of these synaptic kernels summarizes
the strength of transmission at specific types of synapses. While less
biophysically detailed than some previously proposed models
mentioned above, this alpha-kernel model is currently most often
used by experimentalists applying DCM to M/EEG data, e.g.
[30]. We should emphasize, that the purpose of this paper is not to
use a model for providing new insights into the mechanisms of
isoflurane. Instead, we use isoflurane to induce known changes in
the balance of excitatory and inhibitory transmission in order to
test whether our model can infer these net changes correctly, given
measured local field potentials. In the following, we describe our
model in some more detail.
DCM is a generic modeling approach for inferring on the
physiological mechanisms underlying measured neuroimaging
data [31]. For MEG, EEG or LFP data, detailed biophysical
neural mass models serve as generative models for both evoked,
time domain data [4,32] and steady-state, frequency domain data
[29]. In DCM for steady-state responses (SSR) the auto and cross-
spectra, for active regions or sources in the model, are predicted
using their modulation transfer functions, augmented with white
and 1/f type spectral noise [10]. The model describes dynamic
synaptic interactions among connected assemblies of different
neuron types within brain regions (sources) as well as directed
connections between brain regions. Each source is modelled as a
layered macrocolumn comprising three interconnected cell
populations with excitatory spiny stellate cells (assigned to granular
layer IV), excitatory pyramidal cells and inhibitory interneurons
(occupying both supra- and infra-granular layers; [2]). The
dynamics are prescribed by two mathematical operators applied
to the hidden neuronal states of each subpopulation. These are an
input (synaptic) convolution kernel, which converts presynaptic
firing to a postsynaptic membrane potential, and an output
sigmoidal function that relates mean postsynaptic potential to an
average firing rate [33]. Parameters of the model include
maximum excitatory and inhibitory postsynaptic potentials and
excitatory and inhibitory time constants, gain parameters
describing ensemble firing efficiency and intrinsic connectivity
that encode the efficacy of signalling among subpopulations within
a source [10]. In addition, the signalling among sources is
described with extrinsic coupling parameters. Crucially, these
extrinsic connections can be of a forward, backward or lateral
type, depending on the subpopulations targeted by afferents from
the pyramidal population of each source [34]. Specifying different
arrangements of forward and backward connections enables
competing hierarchical architectures to be compared, using
empirical data.
DCM for SSR assumes small perturbations about a dynamic
equilibrium, where the perturbations are caused by endogenous
fluctuations in cortical activity, i.e. white or coloured noise. The
frequency response of a network of regions is described using the
cross-spectral density of outputs, comprising auto- and cross-
spectral components. Variational Bayesian techniques allow us to
invert this generative model given real data and provide posterior
densities over the parameters and the model evidence [35]. A
Bayesian approach allows the model parameters to be constrained
using physiologically plausible priors (c.f. Table 1 in [29]). In this
validation study, the parameters we are particularly interested in
comprise synapticparameters encoding theamplitudeofpopulation
responses to presynaptic glutamate release, from pyramidal and
spiny stellate cells, and to GABA release by interneurons. Since the
postsynaptic kernels encode mass action responses, their magnitude
is a summary index of postsynaptic gain (determined by various
biophysical properties such as receptor density and receptor
‘‘sensitivity’’; e.g., conformational changes under isoflurane).
Previous validation studies of inference on synaptic processing
using this DCM have used microdialysis measurements of
extracellular glutamate levels to predict the parameter estimates
that should be obtained by the model [15]. In this study, we apply
a complementary test of both excitatory and inhibitory neuro-
transmission concomitantly, using different levels of isoflurane and
a within-animal design. Under four levels of isoflurane 1.4%,
1.8%, 2.4% and 2.8%, we recorded local field potential measures
from A1 and PAF under white noise stimulation and in silence,
respectively, for twenty minutes. The spectral data from these time
series formed the basis of our model inversion. Studies of
isoflurane at similar doses in rats have reported a nonlinear
(saturating) increase in GABAergic synaptic transmission with
increasing isoflurane dose [19,36], and a linear decrease in
glutamatergic transmission [37]. We hoped to find that these dose
effects would be reflected in our model parameter estimates.
Materials and Methods
Surgical Treatments
For recording LFPs in Lister hooded rats, a telemetric recording
system (TSE Systems) was assembled, using chronically implanted
epidural silverball electrodes above left and right auditory cortex
in seven animals. In three of these animals, surgery and recordings
were performed bilaterally and the results presented below use
averages over both hemispheres.
Prior to surgery, rats were placed in an anesthesia box that was
perfused with isoflurane (5%) mixed with 30% oxygen (O2) and
70% nitrous oxide (N2O). Once deeply anaesthetized, rats were
transferred into a stereotactic frame and fixated using ear bars and
a tooth bar. During surgery, animals inhaled a similar mixture of
gases through a mask (isoflurane reduced to 2–3%). Body
temperature was kept constant at 37uC using a heating pad
feedback controlled by means of a rectal probe.
Guided by stereotaxic coordinates, two electrodes were
positioned above each hemisphere. When placing the electrodes,
the temporalis muscle was partly removed and a cranial window
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positioned epidurally above the primary auditory area, A1,
(Figure 1) (4 mm posterior to bregma) and above the posterior
auditory field, PAF (6 mm posterior to bregma) 7.6 mm lateral at
a depth of 4 mm, targeting a primary and a non primary auditory
cortex, respectively [38]. A fifth electrode, to which all recorded
signals were referenced, was placed 5 mm anterior to bregma over
the frontal sinus. The telemetry socket, to which electrodes were
soldered, was fixed onto the head with dental cement.
All experimental procedures were approved by the State
Agency for Nature, the Environment and Consumer Protection
under file number 9.93.2.10.35.07.056, controlled by the veteri-
nary authorities of the city of Cologne, and supervised by the
Institute’s animal protection officers.
Pharmacological Interventions and Stimulus Conditions
At the beginning of each experiment, rats were placed in an
isoflurane-perfused box for anaesthesia induction. Afterwards,
animals were transferred into a sound shielded chamber and
placed on the heating pad. During electrophysiological recordings,
the heating pad was not turned on in order not to disturb the
measurements. Temperature was verified between recording
epochs and animals were warmed if necessary.
The experiment started with the lowest dose of isoflurane
anaesthesia (1.4%) and was increased to the next level after
40 min. Each level of anaesthesia was accompanied by LFP
recordings with 20 min continuous white noise stimulation,
followed by 20 min under silence. White noise stimuli had a level
of 83 dB (sampling rate 25 kHz) and were delivered by an RX6
processor and two free field magnetic speakers (Tucker Davis
Technologies, TDT) that were placed with a distance of 15 cm, on
both sides of the rats head. Recordings started immediately after
increase of anaesthesia to the next level.
Electrophysiological Recordings and Spectral Analysis
Electrode recordings were amplified (61000) in the transmitter.
Data were transferred to a receiver at a transmission frequency of
400 to 434 MHz, and amplified again (610). Analogue LFP
recordings were analyzed using a data acquisition system
(DasyLab, Version 9.0, 2005, National Instruments) at a sampling
rate of 2 kHz. Digital filtering was applied online (0.6–60 Hz).
The first ten minutes of each 20 min recording (under white
noise and silence respectively) were extracted from the continuous
time domain data and down-sampled to a sampling rate of
125 Hz. Frequency domain data-features were constructed from
these epochs using a vector auto regression (VAR) model of order
8( p). Channel data y, from the two channels (A1 and PAF) was
modelled as a VAR process (using the SPM Spectral Toolbox:
http://www.fil.ion.ucl.ac.uk, [39]).
yn~A(1)yn{1zA(2)yn{2:::zA(p)yn{pze ð1Þ
The autoregressive coefficients A
(n) and channel noise covari-
ance Eij, estimates were used to compute the cross-spectral
densities for frequencies 1–30 Hz using the following transform:
Hij(v)~
1
A
(1)
ij eivzA
(2)
ij ei2vz:::zA
(p)
ij eipv
gij(v)c~Hij(v)EijHij(v)
 
ð2Þ
Dynamic Causal Modelling and Bayesian Model Selection
Dynamic causal models treat distributed brain networks as a
connected set of neuronal ensembles or sources, where each
ensemble (e.g., macrocolumn) is described by a set of differential
equations. These equations
_ x x~f(x,h,u) ð3Þ
describe the time evolution of states x~(v,g), which are the
membrane potentials vi(t) : i~1,...,7 across and currents
gi(t) : i~1,...,5 flowing through three cell populations in each
macrocolumn and from which a frequency domain response can
be computed (Figure 2A). The measured LFP is assumed to be
dominated by the pyramidal cell membrane potential v6(t)[x due
to the parallel orientation of their apical dendrites [40]. Stellate
cells and interneurons are assumed a priori to contribute less
aggregate signal, comprising about 20% of the measured response
[41]. These cell populations are modelled as layer specific; with
spiny stellate cells in the granular layer reciprocally connected to
pyramidal cells in infra- and supragranular layers. Inhibitory
interneurons in the infra- and supragranular layers are in turn
reciprocally connected to the pyramidal cells (Figure 2A). The
dynamics are described by two functions describing synaptic and
axonal output. The synaptic input-output function prescribes a
convolution operator where presynaptic firing from one popula-
tion is convolved with the postsynaptic response, either excitatory
or inhibitory (Figure 2B) of another, mediated by intrinsic
connections with strengths ci : i~1,...,5 (Figure 2A). The second
operator transforms membrane potentials to an output firing rate
through a static sigmoid, S(v(t)).
The parameters h encode synaptic inputs in terms of the
amplitude of excitatory and inhibitory postsynaptic potentials
(mE/IPSP; He and Hi in Figure 2B), rate constants (ke/i) and the
parameters of the static sigmoidal firing curve (r1,2). Forward,
backward and lateral connections between regions (A
F,B,L)
originate and terminate at specific cell layers (Figure 2A). In this
way DCM for SSR allows one to build hierarchical brain networks
with connectivity rules as suggested by anatomical studies [42]. As
Figure 1. Electrode Placement. Electrode placement (silverball
electrodes) in primary auditory cortex (A1) and posterior auditory field
(PAF) in auditory cortex (A). The anatomical labelling of auditory fields
was taken from [38] and matched to a rat brain from our animals. The
indicated scaling is in mm.
doi:10.1371/journal.pone.0022790.g001
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connections that are largely bidirectional in nature and have
laminar specificity depending on the hierarchical relation of the
areas involved. All connections originate in pyramidal cells (v
region2
6
in Figure 2A). Forward connections terminate in granular layer IV
[43,44]. In contrast, reciprocal backward connections terminate
primarily outside of layer IV [43,45,46] and lateral connections
impinge on all cell layers. While our model lumps together supra-
and infragranular pyramidal cells, it maintains the general
asymmetries of connectional patterns in hierarchically related
areas (Figure 2A).
We tested whether we could infer the known hierarchical
relation of the primary auditory cortex (A1) to the posterior
auditory field (PAF) in the auditory belt region, from the steady
state LFP data. This hypothesis was tested using Bayesian model
selection (BMS) based on the evidence for competing models [47].
Any given DCM represents a specific probabilistic mapping from
experimentally controlled manipulations via neuronal dynamics to
observed data. The goodness of this mapping (model) can be
evaluated by the log model evidence (i.e., the log probability of
observing the data given the model) which trades-off model
accuracy and complexity in a principled way [39,45,47]. When
comparing any two models, their log-evidence difference can be
exponentiated to give the Bayes Factor (BF) which represents the
ratio of the evidences. Conventionally, a Bayes factor BF.150 is
considered very strong evidence in favour of one model over
another (log Bayes Factor of ,5). For larger systems, one could
employ a network discovery approach [48], which would identify
the sparsity structure in terms of which connection set in a fully
connected Bayesian graph (model) best describe the data.
However, here we deal with a very small (two-region) network,
comprising A1 and PAF, with known reciprocal connectivity
where our question was not whether connections played a role in
generating the data but what type of connections generated the
Figure 2. DCM and the Neural Mass Model. A Neural mass model used to represent regions in auditory cortex. Three cell subpopulations
contribute to the ongoing dynamics. These include spiny stellate cells in granular layer IV, pyramidal cells and inhibitory interneurons in extra
granular layers (II & III and V & VI). Intrinsic connections link dynamics between subpopulations in each source. Dynamic states include currents, g, and
membrane potentials v. Extrinsic connections enter at specific cell layers. B Functions controlling ongoing dynamics and their parameterisation. Left:
Excitatory synaptic kernel, which is convolved with the input firing to produce a depolarising change in membrane potential. The function is
parameterised by its height He and time constant. He is allowed to mediate the effects of isoflurane. Increases in He produce different responses, as
per the arrow. Right: Inhibitory synaptic kernel, which is convolved with the input firing to produce a hyperpolarising change in membrane potential.
The function is parameterised by its height Hi and rate constant ki. Both can mediate the effect of isoflurane. Increases in these parameters produce
different responses as per the arrow. C Three competing hypotheses regarding extrinsic connectivity in hierarchical auditory cortex, embodied by
model 1, with forward connections from A1 to PAF and backward connections from PAF to A1 (M1:FB). The reverse architecture is constructed for
model 2 (M2: BF). Model 3 contains lateral connections between the regions (M3: LL).
doi:10.1371/journal.pone.0022790.g002
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and PAF, where forward connections linked A1 to PAF and
backward connections mediated the influences of PAF on A1,
conforming to the hierarchical, forward and backward cortico-
cortical connectivity structure of auditory cortex [49]. A second
(null) hypothesis was instantiated by model 2, where hierarchical
connectivity rules were inverted, with backward connections from
A1 to PAF and forward connections from PAF to A1. Finally a
third model with lateral connections was used to investigate
whether recordings contained hierarchical asymmetry (Figure 2C).
Bayesian Model Inversion and Parameter Estimates
The model was inverted (identified or fitted) by applying it to
the cross-spectral densities from each of the ten hemispheres
separately. In DCM, a variational Bayesian scheme is used, which
factorises the conditional (posterior) density over unknown
parameters into Gaussian marginal densities (here comprising
model parameters and the log-precision of observation noise).
Model inversion furnishes the (approximate) conditional density
q(h), by maximising the negative free energy
F~lnp(ym j ){KL½q(h),p(h y,m j ) ð 4Þ
where KL is the divergence between the true and approximate
posterior. The negative free energy is hence a lower bound on the
log model evidence, ln p(y|m). Note that the model evidence, also
known as the marginal likelihood, evaluates the relative goodness
of models by taking account of both the accuracy with which it can
explain (fit) the empirical data features and the complexity of the
model. The complexity term accounts for both the ‘‘effective
degrees of freedom’’ (number of parameters and their interdepen-
dencies) and differences between the parameter estimate and its a
priori value. Simply speaking, a model is more complex (i) the more
parameters it has, (ii) the more independent (low covariances) and
‘‘flexible’’ (low precision) these parameters are, and (iii) the more
the posterior is required to deviate from the prior to account for
the data [35]. The free energy bound on log-evidence is used for
model selection when testing a series of possible neural
architectures. In this case the forward-backward scheme (model
1) was compared to the backward-forward scheme (model 2). A
fixed effects analysis of the models was performed using the group
Bayes factor [47,50], with log-evidences averaged over hemi-
spheres for those animals with dual recordings. The posterior
densities from the best performing model are then used to provide
the conditional mean and variance of our synaptic parameters of
interest.
In our DCM, we modelled four conditions, corresponding to
1.4%, 1.8%, 2.4% and 2.8% isoflurane. The effect of isoflurane
was modelled separately for each condition, allowing for
unconstrained differences in specific synaptic parameters across
increasing depths of anaesthesia. Three parameters were allowed
to change across anaesthesia levels and thus explain condition
specific effects on the spectral densities. These parameters were the
maximum excitatory postsynaptic potential (EPSP), the maximum
inhibitory postsynaptic potential (IPSP), and the inhibitory rate
constants (ki) of regions A1 and PAF. The quantitative effects of
anaesthesia on these animal-specific parameters (averaged over
hemispheres where applicable) for each region were entered into
an ANOVA with anaesthetic depth as a factor. As we predicted
that excitatory parameters decrease and inhibitory parameters
increase with level of anaesthesia, we used one-tailed probabilities
at P,0.05. To test for particular parametric effects, first and
second order polynomials were later fitted to these animal-specific
modulatory effects. We tested for consistent parametric effects
from the polynomial coefficients using a one-tailed t test.
Results
Spectral Estimates
LFP recordings from A1 and PAF were collected after each
anaesthetic administration for both white noise and silent auditory
conditions. An examination of our time series data revealed burst
activity at low doses of anaesthetic, which dissipated progressively
with higher doses in line with the known burst suppression effects
of isoflurane (Figure 3A) [51]. Cross spectral density measures
were obtained from continuous ten minute epochs, comprising
quasi steady-state representations. Across increasing dose levels,
these spectra reflected the burst suppression as a decrease in low-
frequency power [52,53]. In other words, in the spectral domain,
the features of our data reflected dose-dependent expression of
bursts corresponding to low-frequency oscillations, whose power
declined with increasing levels of anaesthesia. Altogether, our
spectral measures reflect the statistical regularities of the data
across time and provide a quasi steady state summary of the data
across the measurement period.
We examined frequency differences (across levels of anaesthesia)
within traditional EEG bands by binning spectral measures per
animal (n=7) (Figures 3B and 3C). Anaesthetic levels induced a
difference in spectral power in primary auditory cortex for both
white noise and silent conditions in the delta (1–4 Hz; noise:
p,10
28, silence: p,10
24), theta (4–8 Hz; noise: p,10
28, silence:
p,10
24), alpha (8–16 Hz; noise: p,10
27, silence: p,10
26) and
beta (16–30 Hz; noise: p,10
24, silence: p,10
23) bands. Similarly,
the PAF auto-spectra showed a significant effect of anaesthetic
depth (delta; noise: p,10
28, silence: p,10
25, theta; noise:
p,10
210, silence: p,10
26, alpha; noise: p,10
26, silence:
p,10
26, beta; noise: p,10
25, silence: p,10
24). Finally, the
cross-spectral densities comprising the off-diagonal components of
Figures 3B and 3C were also profoundly affected by varying the
depth of anaesthesia (delta; noise: p,10
27, silence: p,10
24, theta;
noise: p,10
210, silence: p,10
25, alpha; noise: p,10
27, silence:
p,10
25, beta; noise: p,10
25, silence: p,10
24).
Model Comparison
These cross-spectra served as data features for model inversion
(see Methods). We tested three models for each data set and
averaged across hemispheres, where dual recordings had been
obtained. Model 1 contained two sources representing A1 and
PAF, with intrinsic dynamics as per Figure 2A with forward
connections from A1 pyramidal cells to layer IV stellate cells in
PAF (Figure 2C). The reciprocal backward connections coupled
PAF pyramidal cells to A1 extra granular layers. In Model 2 the
extrinsic connections were reversed, with forward connections
from PAF to A1 and backward connections from A1 to PAF.
Model 3 used reciprocal lateral connections with afferents from
pyramidal cells targeting all layers (Figure 2C). Using the
(approximate) log- evidence, we tested whether the data were
better explained by model 1, which conformed to the normal
connectivity rules in hierarchical sensory systems [42], or models 2
and 3, which would support higher to lower and equivalent
hierarchical level signal exchange respectively. For this purpose,
we computed the group log-evidence by simply adding the log-
evidences Fs~ln(ysjmi) for each model i~1,2,3 over subjects
s~1,...,7. This assumes the data from each subject are
conditionally independent. The resulting log odds ratio (log group
Bayes factor; lnGBF) of model 1 relative to the second best
performing model, model 2, revealed very strong evidence in
Dynamic Causal Models: A Validation
PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e22790favour of model 1 for both the white noise (lnGBF12=33.21) and
silent (lnGBF12=80.63) conditions (Figure 3D). As can be seen in
Figures 3B and 3C, the model fitted the spectral estimates from
both conditions very accurately.
Parameter Estimates of Glutamatergic and GABAergic
Neurotransmission
Having established the most probable model, we next examined
its parameters encoding glutamatergic and GABAergic neuro-
transmission. Defining 1.4% isoflurane as a baseline, we modelled
condition-specific effects for trials at 1.8%, 2.4% and 2.8%
isoflurane on parameters controlling the maximal amplitude of
EPSPs and IPSPs and inhibitory rate constants ki (see Methods).
The maximum a posteriori (MAP) estimates (i.e., posterior means)
for condition specific effects were used for statistical analysis at the
group level. We first examined the overall changes in excitation
and inhibition relative to baseline and observed significant
decreases (p,0.005) and increases (p,0.05), respectively, in all
stimulus conditions and in both auditory regions. Our analyses did
not indicate any significant changes in inhibitory rate constants in
A1 or PAF.
Dose-dependent analysis of synaptic parameters was performed
using one-way ANOVAs for white noise and silent stimuli at A1
and PAF, with isoflurane depth as a single factor. In A1 there was
a significant effect of isoflurane concentration on EPSP amplitude
(noise: F3,24=6.11, p=0.0031, silence: F3,24=9.26, p=0.0003),
Figures 4A and 4B. There was, however, only a trend towards
differences in A1 inhibitory activity in terms of the postsynaptic
amplitude (noise: F3,24=2.59, p=0.076, silence: F3,24=1.88,
p=0.16 for both stimulus conditions) (Figures 4A and 4C). Post
hoc analysis of primary auditory cortex revealed a significant
decrease in EPSP amplitude for the 1.8% level compared to 1.4%
Figure 3. Modelled Data. A Time series recording from one animal in the noise condition showing increased burst suppression with increasing
isoflurane dose. B Average cross-spectral density matrix representing spectral responses with prominent low frequency components for four
isoflurane dose levels (Hashed line: 1.4%: green, 1.8%: black, 2.4%: blue, 2.8%: grey) as rats heard a white noise stimulus. Significant differences in
spectral power are found for LFP recordings from A1 and PAF and also for their cross-spectra (off-diagonal term). Fits from model 1, averaged across
animals are shown as full lines. C Average cross-spectra as per B, but for recordings and subsequent fits from the silent environment. D Log-evidence
differences at the group level (relative to worse performing model M3: LL), showing very strong evidence in favour of model 1 (M1: FB) for both noisy
and silent environments.
doi:10.1371/journal.pone.0022790.g003
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26, silence: p=0.016, one-tailed t-test), a signifi-
cant decrease for 2.4% compared to 1.8% (noise: p=0.002,
silence: p=0.001, one-tailed t-test), and a trend towards a decrease
for 2.8% compared to 2.4% (noise: p=0.09, silence: p=0.05, one-
tailed t-test). The inhibitory trends were driven by significant
increases for dose level differences at low doses (1.8%.1.4% noise:
p=1 610
26; silence: p=0.0004, one-tailed t-test). Within the PAF
(Figures 4C and 4D), both excitation and inhibition varied:
ANOVA revealed a significant main effect of anaesthetic depth on
EPSPs (noise: F3,24=28.89, p=4 610
28, silence: F3,24=9.05,
p=0.0003) and on IPSPs (noise: F3,24=5.65, p=0.0045, silence:
F3,24=4.21, p=0.016). Post-hoc we observed consecutive decreases
in EPSP height in PAF similar to A1 (1.8.1.4; noise: p=0.0001,
silence: p=0.027, 2.4: .1.8%; noise: p=0.0002 silence:
p=0.0006; 2.8%.2.4%; noise: p=0.01, silence: p=0.09, one
tailed t-test ), and this coincided with a significant increase in
inhibitory neurotransmission as indexed by IPSP for 1.8%
isoflurane compared to baseline (noise: p=0.0003, silence:
p=0.009) that remained high for higher doses (2.4%.1.4%;
noise: p=0.001, silence: p=3 610
26, 2.8%.1.4%: noise: n.s.,
silence: p=0.19, one tailed t-test). Note that EPSP effects in A1
(silence and white noise), EPSP effects in PAF (silence and white
noise) and IPSPs effects in PAF (white noise) survive Bonferroni
correction for 8 multiple comparisons.
Parametric Effects of Isoflurane: dose-response curves
To investigate the parametric effects of isoflurane depth, we
estimated dose-response curves, using the parameter estimates
above. We first used simple linear regressions to establish whether
anaesthetic depth changes excitatory and inhibitory postsynaptic
potentials in the expected direction. We then used a polynomial
dose-response curve to assess the prediction that isoflurane
produces a saturating nonlinear (decreasing) effect at higher doses
(i.e., negative second-order term). A linear curve was fitted to the
Figure 4. Parameter Estimates under Isoflurane. A Average dose responses at 1.4%, 1.8%, 2.4% and 2.8% for He (green) and Hi (grey) for region
A1 from white noise condition (** p,0.005,* p,0.05; error bars denote s.e.m.). Overall trial effects are positive compared to zero baseline at 1.4% for
the inhibitory parameters and negative for excitatory parameters. B Dose responses for He and Hi for region A1 from silence data. C Dose responses
for He and Hi for region PAF from white noise data. D Dose responses for He and Hi for region PAF from silence data.
doi:10.1371/journal.pone.0022790.g004
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a consistent linear effect for EPSP estimates, where slopes were
negative in all animals for noisy and silent conditions (noise:
20.6260.20; mean 6 s.e.m., silence: 20.5160.13); see Figure 5.
Similarly, in PAF, isoflurane produced linear decreases in EPSP
for doses from 1.4% to 2.8% in both environments (noise:
20.4060.05, silence: 20.3260.07). Animals showed variable
positive and negative linear dose response curves for IPSP
measures. However, a second order polynomial model revealed
consistent effects across A1 and PAF for noise and silent stimulus
in all but one case with negative second order effects and positive
linear effects in both conditions (linear coefficient in A1; noise
m=5.1861.96, silence: 4.2061.59, and in PAF; noise:
6.5161.12, silence: 5.5762.58), Figure 5.
Summary
In short, both inference on models and inference on the
parameters of the model selected provide further endorsement of
DCM as a way of accessing hidden architectures and synaptic
physiology, given seemingly unresolved electrophysiological data.
Our model comparison indentified the hierarchical architecture
that was consistent with the known microanatomy of sensory brain
systems, in terms of the laminar specificity of forward and
backward connections. Furthermore, our pharmacological manip-
ulation produced expected quantitative changes in hidden
parameters encoding specific postsynaptic responses. We were
able to generalise these parametric changes over two different
contexts: the presence and absence of auditory noise in the
environment. These two environments test the basic assumption in
DCM for SSR that the cortical nodes can be understood as filters
of surrounding cortical noise. In other words, even in silence there
is sufficient cortical noise (white and pink components) to drive
through the modulatory transfer function embodied by the neural
state equations to produce the spectral output. The fact that no
external perturbation was required to differentiate these models
also points to a key difference between this DCM for steady state
responses and models of evoked transients [5]. That is, while both
DCMs are based on an input-state-output model, DCM for SSR
uses the brain’s own endogenous fluctuations as the input.
Discussion
Using electrophysiological recordings of LFPs during different
levels of isoflurane-induced anaesthesia, we have shown that by
inverting a biologically plausible generative model of cortical
dynamics one can recover latent quantities, such as the membrane
responses to glutamate and GABA receptor binding. These
conclusions were based on epidural recordings, which reflect,
most prominently, membrane potential changes (net excitation
and inhibition) of synchronous activity at pyramidal cell dendrites
in an open field arrangement. Pyramidal cell apical dendrites are
spatially aligned perpendicular to the cortical surface, producing a
linear summation of currents [40,41], while other cells such as
spiny stellate neurons contribute less to the measured response,
due to their closed field arrangement [41] where dendrites are
oriented asymmetrically. By applying similar dipolar models that
account for brain and tissue impedances, source localisation
techniques can be applied to non-invasive EEG and MEG
recordings to recover analogous focal cortical activity [54].
Though fundamentally ill-posed, plausible assumptions about the
sources generating data makes this model inversion possible for
Figure 5. Dose Response Curves. A Linear components of polynomial fits for each animal individually in noise conditions for regions A1 and PAF,
using a linear regression to describe the dose response of (conditional) EPSP effects (green) and using a second order function to describe the dose
response of (conditional) IPSP effects (grey). B Linear components of polynomial fits for each animal individually during silence, for regions A1 and
PAF obtained as per A.
doi:10.1371/journal.pone.0022790.g005
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methodology described and validated here serves as a motivation
for similar non-invasive estimates of neurotransmitter-specific
aspects of synaptic processing [15].
Significance of this study for DCM analysis
DCM was originally designed for the analysis of fMRI time
series [56] to uncover the strength of directed connections between
brain regions activated by experimental perturbation. More
sophisticated neural state equations were used in subsequent
DCM implementations for non-invasive electrophysiological data
(M/EEG) [4,5] and invasive (LFP) recordings [29]. Several
validation studies have shown been performed previously [31].
For example, simultaneous electrophysiological recordings and
fMRI showed that DCM for fMRI could infer the origin of
epileptic activation spread [57]. Other work demonstrated that
DCM for SSR could detect known changes in synaptic
transmission following a developmental perturbation of extracel-
lular glutamate levels [15]. The validation presented here goes
further on two levels. First we have validated the ability of DCM
for SSR to distinguish between excitatory (glutamatergic) vs.
inhibitory (GABAergic) synaptic transmission in cortico-cortical
connections. Secondly, we examine a dose response, showing that
DCM can distinguish between different degrees of drug-induced
synaptic effects. For this, we examined a hierarchical sensory
structure using invasive recordings and inferred a connectivity
architecture that is predicted by anatomical data [42].
Evidence for Architectural and Dose Response Inference
Using electrophysiological recordings, we found that a model
with forward, driving connections from primary auditory cortex to
the posterior auditory field and backward connections in the
opposite direction outperformed a model connected reversely and
a model with lateral connections specifying two regions at the
same hierarchical level. The (first) anatomically plausible model
was inferred with strong evidence for both silent and noisy
environments.
The present view of isoflurane action is that it affects both
excitatory and inhibitory synaptic transmission, influencing pre- as
well as postsynaptic processes; the net effect is a decrease in
excitation and an increase in inhibition [17]. Concerning
inhibitory neurotransmission, increased inhibition due to isoflur-
ane has been attributed to a sensitisation of GABAA receptors [18]
and increased presynaptic release of GABA [19]. Notably, the
increase in inhibition with higher isoflurane levels has been found
to show a nonlinear (saturating) form [19]. In some studies of
spontaneous IPSPs, evidence of a paradoxical reduction of IPSP
amplitude has been observed [58], however when including both
evoked and spontaneous IPSPs, findings show a net increase in the
transfer of negative charge to the postsynaptic cells [59]. Our
model makes no distinction between these two types of post-
synaptic responses and so we consider the parameter estimates in
terms of the drug’s net effects. Moreover pre- and post- synaptic
measures found empirically (for example IPSP amplitude and
frequency) should be included in the expected net effect, and
indicate an overall increase in inhibition. With regard to excitatory
neurotransmission, isoflurane diminishes glutamate signalling
[20,21], probably due to diminished presynaptic release of
glutamate [21,24]. Specifically, at concentrations similar to those
used here, near linear depression of presynaptic glutamate release
has been found [17,37].
It was reassuring to see that our model inversion results were
consistent with these empirical findings, showing a linear decrease
in peak, or maximum EPSP amplitudes with increasing isoflurane
concentration. Moreover, our model parameter estimates also
showed the expected changes in inhibitory synaptic processes with
isoflurane depth, with nonlinear increases in GABAergic neuro-
transmission beyond the 1.4% baseline (Figure 4).
Current Limitations
Our model is limited by the receptor characteristics that
determine its dynamic repertoire. The neural mass model
employed here employs fast linear postsynaptic ion channels, both
at excitatory and inhibitory synapses. Other receptor types not
included in our model, such as glutamatergic NMDA and
cholinergic receptors, have also been shown to be affected by
isoflurane [22,60]. Furthermore the parameters encoding EPSP
and IPSP amplitudes represent lumped coupling parameters that
quantify the collective effect of a number of biophysical processes
such as receptor binding and transmitter reuptake. These are not
separately amenable to the current model assay. Notwithstanding
these limitations, our present investigations complement previous
validation work [15] in demonstrating that DCM can be used to
infer synaptic processes from mass, population measures of
membrane potential fluctuations.
Possible Application and Future Directions
DCM works on the principle that model parameters identifiably
contribute to the dynamic processes controlling measurable brain
responses. In the case of DCM for steady state and evoked
responses, the dynamic processes are described by a neural mass
model and detail how excitatory and inhibitory cells within a given
region interact but also how signals are passed between the regions
themselves. In this work, we have validated the inference that is
made on these unobservable hidden states. Future work will
involve the validation of similar synaptic assays using non-invasive
measures including MEG or EEG where manipulations are
similarly performed using pharmacological agents with known
synaptic consequences. Further work will also examine the validity
of synaptic assays from more complex neural models, e.g. those
including non-linear NMDA channels [61]. Establishing such a
framework would offer great potential to neuroscientists and
clinicians interested in examining normal and pathophysiological
synaptic processing in humans at a combined behavioural, brain
network and synaptic level. This may be of particular relevance for
establishing physiologically interpretable assays of synaptic func-
tion which hold promise for diagnostic categorisation of patients in
psychiatric spectrum disorders, such as schizophrenia [62]. The
approach may also help to elucidate synaptic effects induced by
novel drug compounds.
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